Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Hontecillas

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Gut Microbes|May 18, 2013
Animal models of enteroaggregative Escherichia coli infectionCasandra W Philipson, Josep Bassaganya-Riera, Raquel Hontecillas
Medical Hypotheses|October 19, 2006
Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetesWilliam E Barbeau, Josep Bassaganya-Riera, Raquel Hontecillas
Clinical Nutrition (Edinburgh, Scotland)|October 21, 2006
Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutritionAmir J Guri, Raquel Hontecillas, Josep Bassaganya-Riera
Clinical Nutrition (Edinburgh, Scotland)|March 19, 2010
Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltrationAmir J Guri, Raquel Hontecillas, Josep Bassaganya-Riera
Journal of Theoretical Biology|April 6, 2010
Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel diseaseKatherine Wendelsdorf, Josep Bassaganya-Riera, Raquel Hontecillas, et al.
Gut Microbes|April 24, 2014
Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infectionBarbara Kronsteiner, Josep Bassaganya-Riera, Noah Philipson, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
Preventive and prophylactic mechanisms of action of pomegranate bioactive constituentsMonica Viladomiu, Raquel Hontecillas, Pinyi Lu, et al.
Cellular Immunology|May 9, 2009
PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammationJosep Bassaganya-Riera, Sarah Misyak, Amir J Guri, et al.
Current Drug Targets|March 18, 2014
Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetesPinyi Lu, Raquel Hontecillas, Casandra W Philipson, et al.
Clinical and Translational Science|January 11, 2025
Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Gut Microbes|May 18, 2013
Animal models of enteroaggregative Escherichia coli infectionCasandra W Philipson, Josep Bassaganya-Riera, Raquel Hontecillas
Medical Hypotheses|October 19, 2006
Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetesWilliam E Barbeau, Josep Bassaganya-Riera, Raquel Hontecillas
Clinical Nutrition (Edinburgh, Scotland)|October 21, 2006
Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutritionAmir J Guri, Raquel Hontecillas, Josep Bassaganya-Riera
Clinical Nutrition (Edinburgh, Scotland)|March 19, 2010
Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltrationAmir J Guri, Raquel Hontecillas, Josep Bassaganya-Riera
Journal of Theoretical Biology|April 6, 2010
Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel diseaseKatherine Wendelsdorf, Josep Bassaganya-Riera, Raquel Hontecillas, et al.
Gut Microbes|April 24, 2014
Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infectionBarbara Kronsteiner, Josep Bassaganya-Riera, Noah Philipson, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
Preventive and prophylactic mechanisms of action of pomegranate bioactive constituentsMonica Viladomiu, Raquel Hontecillas, Pinyi Lu, et al.
Cellular Immunology|May 9, 2009
PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammationJosep Bassaganya-Riera, Sarah Misyak, Amir J Guri, et al.
Current Drug Targets|March 18, 2014
Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetesPinyi Lu, Raquel Hontecillas, Casandra W Philipson, et al.
Clinical and Translational Science|January 11, 2025
Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Pageof 13